Cytokine release syndrome as a consequence of check point inhibitors nivolimumab and iplimumab

Authors : Amrita Shah, Pradeep Rangappa, Ipe Jacob, Karthik Rao, Neelesh Reddy

DOI : 10.18231/j.ijpo.2022.096

Volume : 9

Issue : 4

Year : 2022

Page No : 392-394


 


Citation Data


Related Articles

Biological bone tissue engineering with adipose stem cell combined gene therapy: A future prospect in treating oral peri-implant defects

Akheel Mohammad, A Rizwan Ali

Level of IMA in newly diagnosed untreated hypothyroid subjects diagnosed during routine screening at Tertiary Care Hospital in North India

Poonam Agrawal, Niket Verma, Binita, Sumita Sethi, Pratima

Prostate cancer in a 16-year old — Is there a new shift?

Shyamji Rawat, V S Haritha, Mishi Tiwari, Rahul R Verma

Erector spinae plane block OR modified pectoralis block for postoperative analgesia after modified radical mastectomy: Which is better ???

Shweta Mahajan, Anshit Abhi Pathania, Rita Khanoria

Open myomectomy as an approach to removal of multiple large uterine fibroids

Anshu Baser, Akriti Gupta, D M Dabholkar, Sushil Kumar

Spectrum of tumour and tumour-like lesions of bone in a Tertiary Care Hospital in North Karnataka, India

Gayathri T., Shashikala V., Sody Rekha

Authors’ response to comments on The effect of 2% pilocarpine on depth of field in different time intervals among presbyopic subjects

Ashith Tripathi, Sachitanand Singh, Iqra Jamal Khan, Krishnasri Padamandala, Sebin C Sebastian

Spinal Rosai Dorfman disease: A rare case scenario

Roshni P. S, Sudha Haridas, Chothisha Poovan

Gaucher’s disease is a common storage disorder but rare entity: Two case report

Kartavya Kumar Verma*, Nighat Hussain Hussain